Treatment was discontinued due to adverse events in 21 patients 4.9% treated with a daily dose and 10 4.3% with two daily doses 11. Differences between groups were not observed during the time until treatment was discontinued.
Se produjo la suspensión del tratamiento por acontecimientos adversos en 21 pacientes 11 [4,9%] tratados con una dosis diaria y 10 [4,3%] con dos dosis diarias; no se observaron diferencias entre los grupos en cuanto al tiempo hasta la suspensión del tratamiento.